POMDOCTOR Ltd
POM- Exchange
- Nasdaq
- Industry
- Retail-Miscellaneous Retail
- SEC CIK
- 0001877971
No open-market purchases or sales by POMDOCTOR Ltd insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $38.4K in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, −4 vs. previous quarter
- 6
- 13F valueReported value at the end of Q2 2026
- $38.4K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding POM, Q2 2026
No superinvestor reported holding POM at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by POMDOCTOR Ltd insiders from Form 4, newest first.
No open-market purchases or sales by POMDOCTOR Ltd insiders are on file.
Top 10 13F holders, Q2 2026
The largest institutional positions in POMDOCTOR Ltd at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 21,273 | $30.8K | 0.00% | −343,330−94.2% | Reduced |
| UBS Group AG | 3,463 | $5.02K | 0.00% | −13,180−79.2% | Reduced |
| Caitong International Asset Management Co., Ltd | 893 | $1.29K | 0.00% | −30,692−97.2% | Reduced |
| SRS Capital Advisors, Inc. | 722 | $1.05K | 0.00% | +722 | New |
| Steward Partners Investment Advisory, LLC | 111 | $161 | 0.00% | −1,889−94.5% | Reduced |
| Rhumbline Advisers | 41 | $60 | 0.00% | −709−94.5% | Reduced |